449 related articles for article (PubMed ID: 11997476)
1. Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure.
Holtwick R; Gotthardt M; Skryabin B; Steinmetz M; Potthast R; Zetsche B; Hammer RE; Herz J; Kuhn M
Proc Natl Acad Sci U S A; 2002 May; 99(10):7142-7. PubMed ID: 11997476
[TBL] [Abstract][Full Text] [Related]
2. Increased sensitivity to endothelial nitric oxide (NO) contributes to arterial normotension in mice with vascular smooth muscle-selective deletion of the atrial natriuretic peptide (ANP) receptor.
Sabrane K; Gambaryan S; Brandes RP; Holtwick R; Voss M; Kuhn M
J Biol Chem; 2003 May; 278(20):17963-8. PubMed ID: 12637561
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide.
Sabrane K; Kruse MN; Fabritz L; Zetsche B; Mitko D; Skryabin BV; Zwiener M; Baba HA; Yanagisawa M; Kuhn M
J Clin Invest; 2005 Jun; 115(6):1666-74. PubMed ID: 15931395
[TBL] [Abstract][Full Text] [Related]
4. Hypervolemic hypertension in mice with systemic inactivation of the (floxed) guanylyl cyclase-A gene by alphaMHC-Cre-mediated recombination.
Skryabin BV; Holtwick R; Fabritz L; Kruse MN; Veltrup I; Stypmann J; Kirchhof P; Sabrane K; Bubikat A; Voss M; Kuhn M
Genesis; 2004 Aug; 39(4):288-98. PubMed ID: 15287002
[TBL] [Abstract][Full Text] [Related]
5. Chronic endothelium-dependent regulation of arterial blood pressure by atrial natriuretic peptide: role of nitric oxide and endothelin-1.
Sabrane K; Kruse MN; Gazinski A; Kuhn M
Endocrinology; 2009 May; 150(5):2382-7. PubMed ID: 19179430
[TBL] [Abstract][Full Text] [Related]
6. The heart communicates with the endothelium through the guanylyl cyclase-A receptor: acute handling of intravascular volume in response to volume expansion.
Schreier B; Börner S; Völker K; Gambaryan S; Schäfer SC; Kuhlencordt P; Gassner B; Kuhn M
Endocrinology; 2008 Aug; 149(8):4193-9. PubMed ID: 18450968
[TBL] [Abstract][Full Text] [Related]
7. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
[TBL] [Abstract][Full Text] [Related]
8. Heart-Microcirculation Connection: Effects of ANP (Atrial Natriuretic Peptide) on Pericytes Participate in the Acute and Chronic Regulation of Arterial Blood Pressure.
Špiranec Spes K; Chen W; Krebes L; Völker K; Abeßer M; Eder Negrin P; Cellini A; Nickel A; Nikolaev VO; Hofmann F; Schuh K; Schweda F; Kuhn M
Hypertension; 2020 Nov; 76(5):1637-1648. PubMed ID: 32951468
[TBL] [Abstract][Full Text] [Related]
9. Natriuretic peptides buffer renin-dependent hypertension.
Demerath T; Staffel J; Schreiber A; Valletta D; Schweda F
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1489-98. PubMed ID: 24717731
[TBL] [Abstract][Full Text] [Related]
10. Smooth muscle-specific deletion of nitric oxide-sensitive guanylyl cyclase is sufficient to induce hypertension in mice.
Groneberg D; König P; Wirth A; Offermanns S; Koesling D; Friebe A
Circulation; 2010 Jan; 121(3):401-9. PubMed ID: 20065162
[TBL] [Abstract][Full Text] [Related]
11. Diverging vasorelaxing effects of C-type natriuretic peptide in renal resistance arteries and aortas of GC-A-deficient mice.
Steinmetz M; Potthast R; Sabrane K; Kuhn M
Regul Pept; 2004 Jun; 119(1-2):31-7. PubMed ID: 15093694
[TBL] [Abstract][Full Text] [Related]
12. Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice.
Nakanishi M; Saito Y; Kishimoto I; Harada M; Kuwahara K; Takahashi N; Kawakami R; Nakagawa Y; Tanimoto K; Yasuno S; Usami S; Li Y; Adachi Y; Fukamizu A; Garbers DL; Nakao K
Hypertension; 2005 Aug; 46(2):441-7. PubMed ID: 15998711
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide modulation of albumin clearance and contrast agent permeability in mouse skeletal muscle and skin: role in regulation of plasma volume.
Curry FR; Rygh CB; Karlsen T; Wiig H; Adamson RH; Clark JF; Lin YC; Gassner B; Thorsen F; Moen I; Tenstad O; Kuhn M; Reed RK
J Physiol; 2010 Jan; 588(Pt 2):325-39. PubMed ID: 19948658
[TBL] [Abstract][Full Text] [Related]
14. β Cell-specific deletion of guanylyl cyclase A, the receptor for atrial natriuretic peptide, accelerates obesity-induced glucose intolerance in mice.
Tauscher S; Nakagawa H; Völker K; Werner F; Krebes L; Potapenko T; Doose S; Birkenfeld AL; Baba HA; Kuhn M
Cardiovasc Diabetol; 2018 Jul; 17(1):103. PubMed ID: 30016962
[TBL] [Abstract][Full Text] [Related]
15. Endothelial C-Type Natriuretic Peptide Acts on Pericytes to Regulate Microcirculatory Flow and Blood Pressure.
Špiranec K; Chen W; Werner F; Nikolaev VO; Naruke T; Koch F; Werner A; Eder-Negrin P; Diéguez-Hurtado R; Adams RH; Baba HA; Schmidt H; Schuh K; Skryabin BV; Movahedi K; Schweda F; Kuhn M
Circulation; 2018 Jul; 138(5):494-508. PubMed ID: 29626067
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of atrial natriuretic peptide ANP-C receptor is associated with alterations in G-protein expression in A10 smooth muscle cells.
Anand-Srivastava MB
Biochemistry; 2000 May; 39(21):6503-13. PubMed ID: 10828966
[TBL] [Abstract][Full Text] [Related]
17. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.
Kishimoto I; Rossi K; Garbers DL
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2703-6. PubMed ID: 11226303
[TBL] [Abstract][Full Text] [Related]
18. The guanylyl cyclase-deficient mouse defines differential pathways of natriuretic peptide signaling.
Lopez MJ; Garbers DL; Kuhn M
J Biol Chem; 1997 Sep; 272(37):23064-8. PubMed ID: 9287305
[TBL] [Abstract][Full Text] [Related]
19. Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice.
Werner F; Kojonazarov B; Gaßner B; Abeßer M; Schuh K; Völker K; Baba HA; Dahal BK; Schermuly RT; Kuhn M
Basic Res Cardiol; 2016 Mar; 111(2):22. PubMed ID: 26909880
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic factor as a volume regulator.
Inagami T
J Clin Pharmacol; 1994 May; 34(5):424-6. PubMed ID: 7916352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
